Trial
NCT04754425
Erdafitinib for the Treatment of Patients With Castration-Resistant Prostate Cancer
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
M.D. Anderson Cancer Center
Collaborators
—
Condition
Castration-Resistant Prostate Carcinoma
Intervention
Biopsy
Why stopped
\<75% participation
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-02-06